To the Editor The editorial by Schwartz and Woloshin1 in a recent issue of JAMA Internal Medicine raises important legal and ethical questions about the role of advertising in helping inform patients about possible treatment options and the choice of where to receive care.
We concur with the recommendation that a common standard should apply to all cancer care advertising, regardless of the for-profit or not-for-profit status of the institution. These recommendations should be developed by an industry task force composed of oncologists and clinicians who are actively practicing in oncology-related fields and guided by input from those we serve: patients with cancer and their caregivers.